Japanese Infrastructure Stock News

Cold Jet bv announced that it has partnered with Nippon Sanso Holdings to launch a fully automated dry ice production and CO2 recovery facility in Köping, Sweden, capable of producing 2.2 tons of dry ice per hour for airline, food, pharmaceutical, and industrial cleaning customers across the Nordic region. The project’s integrated CO2 recovery, robotics, and automated packaging not only cut liquid CO2 costs and reduce emissions, but also deepen Nippon Sanso’s role in higher-value,...

Earlier this month, Takeda Pharmaceutical announced that its oral TYK2 inhibitor zasocitinib delivered statistically superior Phase 3 results versus deucravacitinib in adults with moderate-to-severe plaque psoriasis, with complete skin clearance at week 16 and a safety profile consistent with prior studies. In parallel, Takeda withdrew a ¥132 billion shelf registration from 2022 and filed a new ¥240 million shelf registration, moves that may signal a recalibration of its potential equity...

Tomoe Engineering (TSE:6309) has reported a clean set of Q2 2026 numbers, with revenue at about ¥15.5 billion and basic EPS of ¥57.26, backed by net income of ¥1.7 billion. The company’s quarterly revenue has moved from roughly ¥12.96 billion in Q4 2025 to ¥15.33 billion in Q1 2026 and ¥15.52 billion in Q2 2026. Over the same period, EPS has shifted from ¥16.46 to ¥37.61 and then ¥57.26, giving investors a clearer view of the current earnings run rate. With a net profit margin of 6.9%...

Markets are juggling inflation worries, shifting central bank policies and energy driven price swings, so a solid core of lower risk stocks can be especially useful. That is where the Low-Risk Leaders screener comes in, focusing on resilient companies with strong balance sheets and the lowest risk scores in the model. Instead of chasing the hottest story, you lean on financial strength and consistency to anchor your portfolio while still seeking returns. In this article, you will see three...

Ain Holdings (TSE:9627) closed FY 2026 with Q4 revenue of ¥172.9 billion and basic EPS of ¥200.37, backed by trailing 12 month revenue of ¥647.8 billion and EPS of ¥491.60 as earnings growth over the last year reached 86.4%. Over recent periods, the company has seen revenue move from ¥456.8 billion and EPS of ¥264.31 in the trailing 12 months to Q4 FY 2025, to ¥647.8 billion and EPS of ¥491.60 in the latest trailing period, with net profit margin at 2.7% compared with 2.0% a year earlier. For...

i-mobileLtd (TSE:6535) has posted Q3 2026 revenue of ¥2,382 million with basic EPS of ¥7.31, alongside trailing 12 month revenue of ¥22.1 billion and EPS of ¥44.24 that frame the latest quarter against a fuller year of results. Over recent quarters the company has seen revenue move between ¥6,680 million in Q2 2026 and ¥10.1 billion in Q1 2026, while basic EPS has ranged from ¥0.75 to ¥35.41, giving investors a broad view of how earnings power has shifted through the year. With trailing net...

Toho (TSE:8142) has opened Q1 2027 with revenue of ¥67.8b and basic EPS of ¥42.93, set against trailing twelve month revenue of ¥266.3b and EPS of ¥458.72 that came with 7.6% earnings growth and a 1.8% net margin. Over recent periods, revenue has moved from ¥61.5b in Q1 2026 to ¥67.8b in Q1 2027, while basic EPS has shifted from ¥27.89 to ¥42.93, providing a clearer view of the top line scale and per share earnings profile going into this quarter. With that backdrop of steady margins, the...

3-D Matrix (TSE:7777) closed out FY 2026 with Q4 revenue of ¥3.5b and basic EPS of ¥14.24, rounding off a year in which trailing twelve month revenue reached ¥10.9b and EPS came in at ¥34.88. The company has seen quarterly revenue move from ¥1.9b in Q4 FY 2025 to ¥3.5b in Q4 FY 2026, while basic EPS shifted from a loss of ¥10.11 per share to a profit of ¥14.24 per share over the same period, with trailing twelve month EPS moving from a loss of ¥25.20 to a profit of ¥34.88. For investors, the...

NEOJAPAN (TSE:3921) Q1 2027 results in focus NEOJAPAN (TSE:3921) has opened Q1 2027 with total revenue of ¥2.1 billion and basic EPS of ¥34.74, backed by trailing twelve month EPS of ¥131.92 and net income of ¥1,848.64 million that followed earnings growth of 19.6% over the past year. The company has seen quarterly revenue move from ¥1,996.38 million and EPS of ¥31.97 in Q1 2026 to ¥2,077 million and EPS of ¥34.74 in Q1 2027, while trailing twelve month revenue has progressed from ¥7.26...

GA technologies (TSE:3491) has reported a busy Q2 2026, with revenue of ¥83,837 million and Basic EPS of ¥60.03, compared with trailing twelve month EPS of ¥90.90 and net income of ¥3,731 million. Over recent quarters the company’s revenue has moved from ¥48,322 million in Q1 2025 to ¥83,837 million in Q2 2026, while quarterly Basic EPS has ranged from a loss of ¥11.38 in Q1 2026 to ¥60.03 in the latest quarter. Investors are weighing this solid top line scale against still thin margins. See...

Kamakura Shinsho (TSE:6184) has opened Q1 2027 with revenue of ¥2.2b and basic EPS of ¥4.73, setting the tone for how the new fiscal year compares with its recent track record. The company has seen quarterly revenue move from ¥2.0b in Q1 2026 to ¥2.2b in Q1 2027, while basic EPS shifted from ¥4.22 to ¥4.73 over the same period. This performance comes against a backdrop of five year earnings growth and a trailing net profit margin that has eased from 10.1% to 9.4%, putting margins and their...

Computer Engineering & Consulting (TSE:9692) opened Q1 2027 with revenue of ¥16.8 billion and net income of ¥1.6 billion, translating to basic EPS of ¥50.98, against a backdrop of 38.7% year over year earnings growth and an 8.1% net profit margin over the last 12 months. Over recent quarters, revenue has moved from ¥14.3 billion in Q1 2026 to ¥18.6 billion in Q4 2026 before landing at ¥16.8 billion in Q1 2027. Quarterly EPS shifted from ¥39.51 to ¥51.56 and now ¥50.98, while trailing 12 month...

Visional (TSE:4194) has just posted Q3 2026 results with revenue of ¥26.5 billion and basic EPS of ¥119.80, putting concrete numbers around a year where earnings grew 21.7% and are forecast in the data to grow about 12.6% annually alongside revenue growth forecasts of about 13.8% a year. The company has seen quarterly revenue move from ¥18.2 billion in Q2 2025 to ¥26.5 billion in Q3 2026, while quarterly basic EPS over the same period ranged from ¥88.14 to ¥136.54 and the trailing net profit...

If you are wondering whether ARCHION's current share price offers value or just more volatility, this article walks through what the numbers actually say about the stock. The share price closed at ¥282.0, with returns down 9.6% over the past week and past month, 29.1% year to date, and 24.1% over the last year. This will shape how you think about both risk and potential reward. Recent coverage around ARCHION has focused on keeping investors informed with evergreen analysis, which often...

Timee (TSE:215A) has put out a clean Q2 2026 print, with revenue of ¥10.1b and basic EPS of ¥9.95, set against a trailing twelve month picture that shows revenue of ¥38.8b and EPS of ¥51.69. Over the past six reported quarters, the company has seen revenue move from ¥7.8b and EPS of ¥12.65 in Q2 2025 to ¥9.5b and EPS of ¥14.85 in Q4 2025, then to ¥10.9b and EPS of ¥14.30 in Q1 2026, before landing at the latest Q2 figures. This gives investors a clear view of how sales and earnings have...

IKK Holdings (TSE:2198) has posted Q2 2026 revenue of ¥5,524.1 million and basic EPS of ¥2.39, with trailing twelve month EPS at ¥77.73 and revenue at ¥22,972 million framing the latest quarter against a much larger earnings base. Over recent periods the company has seen quarterly revenue move between ¥5,355.7 million and ¥6,593.3 million, while basic EPS has ranged from ¥2.39 to ¥52.51, giving you a clear view of how the current print sits within recent swings in profitability. With trailing...

Chugai Pharmaceutical (TSE:4519) has drawn fresh attention after recent share price moves, with the stock down about 4.5% over the past month and roughly 20% over the past 3 months. See our latest analysis for Chugai Pharmaceutical. That recent 4.5% decline in the 1 month share price sits within a wider loss of about 20% over 3 months, even as the 1 year total shareholder return of 3.4% and 3 year total shareholder return of 87.7% point to a much stronger longer run outcome. If this sort of...

As the Asian markets navigate the complexities of economic recovery and inflationary pressures, investors are increasingly looking for stable income sources amidst global uncertainties. In this context, dividend stocks stand out as a potentially attractive option, offering regular income and potential capital appreciation while aligning with current market dynamics.

In early June 2026, MBRYONICS announced an MoU with NTT to jointly develop coherent optical transceivers for space applications, while Keysight, NTT DOCOMO and NTT reported progress on 6G channel modeling and distributed MIMO simulation, and Transatel’s Ubigi brand appointed Esteban Ocon as global ambassador for its travel eSIM service. Taken together, these initiatives highlight NTT’s push to extend its communications expertise beyond terrestrial networks into space, next‑generation 6G...

Kadokawa stock overview after recent performance moves Kadokawa (TSE:9468) has drawn fresh investor attention after a mixed stretch of returns, with the stock up 1.3% on the day but down about 5.7% over the past month. See our latest analysis for Kadokawa. The recent 1-day share price return of 1.29% and 7-day share price return of 2.10% come after a softer 30-day share price return. The 1-year total shareholder return is down 9.83% yet still ahead over five years with a 52.90% total...

Inflation worries, energy price shocks and shifting central bank policies are putting weaker companies under pressure, while balance sheet strength and disciplined profitability stand out more than ever. When rates are uncertain and earnings quality really matters, stocks with high return on equity, resilient past performance and sound finances can offer a clearer way to focus on business quality rather than short term noise. This article highlights 3 stocks from a Solid Balance Sheet and...

Recent coverage has put TRIAL Holdings (TSE:141A) in the spotlight as one of Asia’s top undervalued stocks, citing strong fundamentals and a sizeable discount to estimated intrinsic value. See our latest analysis for TRIAL Holdings. Investor interest has picked up after TRIAL Holdings was highlighted as undervalued, with the share price up 2.04% over one day and 6.82% over seven days, even though the 30 day share price return is down 34.18% and the 90 day share price return is down 29.10%,...

OSG stock: recent performance and context OSG (TSE:6136) has caught investor attention after a strong total return over the past year, with the stock also showing a sizeable gain over the past 3 years and 5 years. See our latest analysis for OSG. Short term, the share price has eased back with a 30 day share price return of 5.39% and a 7 day return of 1.43%, but momentum over the past 90 days and the 1 year total shareholder return of 107.35% still points to strong underlying interest. If you...

Pan Pacific International Holdings (TSE:7532) released its May 2026 sales update, highlighting year over year gains in both comparable and all store sales across its domestic retail and discount store operations. See our latest analysis for Pan Pacific International Holdings. At a share price of ¥867.8, the stock has risen 2.21% over the last day and 5.05% over the past week, but is still down 14.08% over 90 days. The 3 year total shareholder return of 76.66% and 5 year total shareholder...